Concord Drugs standalone net profit rises 50.00% in the September 2019 quarter

Sales rise 22.63% to Rs 14.09 crore

Net profit of Concord Drugs rose 50.00% to Rs 0.06 crore in the quarter ended September 2019 as against Rs 0.04 crore during the previous quarter ended September 2018. Sales rose 22.63% to Rs 14.09 crore in the quarter ended September 2019 as against Rs 11.49 crore during the previous quarter ended September 2018. ParticularsQuarter EndedSep. 2019Sep. 2018% Var.Sales14.0911.49 23 OPM %6.328.44 -PBDT0.460.60 -23 PBT0.090.05 80 NP0.060.04 50

Powered by Capital Market - Live News